(Press-News.org) ARLINGTON HEIGHTS, ILL. -- Asthma is a disease that mostly affects young boys and adult women. And according to a new study, women in their 40s and 50s with asthma are hospitalized more than twice as often as men in the same age group. The 10-year study is published in the September issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).
"Until puberty, boys have higher rates of asthma than girls," said Robert Yao-wen Lin, MD, allergist and lead study author. "Then, during the menopausal years, women's hospitalization rates are double those of men in the same age group. This could indicate that asthma may have distinct biological traits."
The National Impatient Sample databases for 2000-2010 were used to calculate the ratio of female to male hospitalization rates for different decades of adult life. The highest rate of difference was found in the fifth and six decade. Common coexisting conditions, such as cigarette smoking and obesity were taken into account.
"This study reinforces that asthma is a women's health issue," said John Oppenheimer, MD, ACAAI Fellow and associate editor of Annals of Allergy, Asthma & Immunology. "There is a need for more prevention and early intervention to reduce asthma hospitalization in menopausal women and reduce healthcare costs."
The American College of Allergy, Asthma and Immunology suggests that women in their 40s and 50s with asthma make an appointment with their allergist and ask these questions:
Do I need any change in my medications?
What are the symptoms associated with the risk of a severe asthma attack during menopause?
How do I keep my asthma in check and avoid needing emergency room or hospitalized treatment?
Everyone with allergies and asthma should be able to feel good, be active all day and sleep well at night. No one should accept less. For more information about allergy and asthma, and to locate an allergist in your area, visit AllergyAndAsthmaRelief.org
###
About ACAAI
The ACAAI is a professional medical organization of more than 5,700 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit AllergyAndAsthmaRelief.org. Join us on Facebook, Pinterest and Twitter.
Menopausal women at greater risk for asthma hospitalization
Study reports rates more than twice that of men in same age group
2013-09-03
ELSE PRESS RELEASES FROM THIS DATE:
Friends' Facebook, Myspace photos affect risky behavior among teens
2013-09-03
LOS ANGELES — Teenagers who see friends smoking and drinking alcohol in photographs posted on Facebook and Myspace are more likely to smoke and drink themselves, according to a new study from the University of Southern California (USC).
"Our study shows that adolescents can be influenced by their friends' online pictures to smoke or drink alcohol," said Thomas W. Valente, Ph.D., professor of preventive medicine at the Keck School of Medicine of USC and the study's principal investigator. "To our knowledge, this is the first study to apply social network analysis methods ...
Low BMI is a risk factor for CVD in hypertensive patients with diabetes
2013-09-03
Amsterdam, The Netherlands – Tuesday 3 September 2013: Low BMI is a risk factor for CVD in hypertensive patients with diabetes, according to research presented at the ESC Congress today by Dr Takanori Nagahiro from Japan. The findings provide evidence for an obesity paradox in hypertensive patients with glucose intolerance.
Dr Nagahiro said: "Obesity is a risk factor for cardiovascular disease (CVD) but several studies have reported that low body mass index (BMI, kg/m2) was associated with worse cardiovascular outcome compared to middle or higher BMI. This strange phenomenon ...
Fear of holes may stem from evolutionary survival response
2013-09-03
What do lotus flowers, soap bubbles, and aerated chocolate have in common? They may seem innocuous, even pleasant, but each of these items is a trigger for people who report suffering from trypophobia, or the fear of holes. For trypophobes, the sight of clusters of holes in various formations can cause intensely unpleasant visceral reactions.
New research from psychological scientists Geoff Cole and Arnold Wilkins of the University of Essex suggests that trypophobia may occur as a result of a specific visual feature also found among various poisonous animals. The findings ...
Breakthrough model holds promise for treating Graves' disease
2013-09-03
Chevy Chase, MD—Researchers have developed the first animal model simulating the eye complications associated with the thyroid condition Graves' disease, a breakthrough that could pave the way for better treatments, according to a recent study accepted for publication in The Endocrine Society's journal Endocrinology.
Graves' disease is an autoimmune disorder that causes the body to produce antibodies that attack the thyroid gland. The condition causes the thyroid gland to become overactive and produce too much thyroid hormone. If left untreated, it can lead to heart failure ...
Tissue loss triggers regeneration in planarian flatworms
2013-09-03
CAMBRIDGE, Mass. (September 3, 2013) – Unlike humans, planarian flatworms have the remarkable ability to regrow any missing body part, making them an ideal model with which to study the molecular basis of regeneration.
Over the years scientists have learned that planarians mount recovery responses that differ depending on the severity of the injury they suffer. For example, a worm with a cut or a puncture wound reacts at the cellular and molecular levels quite differently from one that loses its head or tail. What has remained unclear, however, is just exactly how these ...
French Tour de France cyclists live longer than their non-cyclist countrymen
2013-09-03
AMSTERDAM, The Netherlands – French participants in the Tour de France between 1947-2012 lived longer than their same-age French counterparts according to the results of a study marking the centenary of the race this year.
"In the context of recent concerns regarding performance-enhancing techniques and the potential negative health effects of excessive high-level physical activity, data on the long-term outcomes and causes of death in elite endurance cyclists is of particular interest," said Xavier Jouven, MD, PhD, from the Sudden Death Expertise Center in Paris, France.
"Although ...
Biomarker assessment in suspected ACS could be practice-changing: BIC-8 results
2013-09-03
AMSTERDAM, The Netherlands – An emergency department strategy that uses two biomarkers to triage patients with suspected acute coronary syndrome (ACS) can increase the rate of early, safe hospital discharge, according to results of the Biomarkers in Cardiology 8 (BIC-8) trial.
"This biomarker strategy using a state-of-the-art quantitative troponin assay in combination with an ultrasensitive copeptin assay has the potential to change clinical practice with high patient safety," said lead investigator Martin Möckel, MD, PhD, from Charité - Universitätsmedizin Berlin, in ...
Despite missing primary efficacy endpoint, ATOMIC-AHF identifies positive trends
2013-09-03
AMSTERDAM, The Netherlands – Omecamtiv mecarbil, a cardiac myosin-activator, did not achieve its primary efficacy endpoint in reducing dyspnoea (shortness of breath) in patients with acute heart failure, according to the results of the phase II ATOMIC-AHF (Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure) study.
However, a cohort which received the highest dose of the drug showed greater dyspnoea relief compared with placebo, and there were also other favourable dose and concentration-related trends, noted lead investigator John ...
Hot Line IV: Late-breaking trials on heart failure and acute coronary syndrome
2013-09-03
AMSTERDAM, The Netherlands – The blood pressure lowering drug aliskiren did not improve coronary artery disease when given to patients who had prehypertension, results of the Aliskiren Quantitative Atherosclerosis Regression Intravascular Ultrasound Study (AQUARIUS) reveal.
The findings, reported at the European Society of Cardiology Congress with simultaneous publication in the Journal of the American Medical Association, offer new insight into the value of lowering blood pressure beyond prehypertensive goals, suggested lead investigator Stephen Nicholls MBBS, PhD, Deputy ...
TAVI is safe alternative to redo cardiac surgery
2013-09-02
Use of bioprosthetic heart valves has dramatically increased (from 18% in 1991 to 59% in 2003), mainly in older patients with comorbidities. This is due to the increased risk of bleeding complications associated with lifelong use of anticoagulation for mechanical prostheses.
But structural valve deterioration is one the main complications associated with bioprosthetic heart valves. In large registries including more than 300 000 patients undergoing aortic valve replacement the reoperation rate for patients receiving a bioprosthesis was 3.1% at 11-13 years of follow-up ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] Menopausal women at greater risk for asthma hospitalizationStudy reports rates more than twice that of men in same age group